Cue Biopharma CUE
NASDAQ CUE
$18.89 -0.06 (-0.32%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cue Biopharma (CUE) Other Accumulated Expenses (2017 - 2018)

Updated

Cue Biopharma (CUE) posted Other Accumulated Expenses of $79,188 for Q4 2018, down 19.1% from $97,857 a year earlier.

Analysis

Cue Biopharma (CUE) Other Accumulated Expenses (2017 - 2018) Analysis & Trends

  • In prior years, Cue Biopharma's Other Accumulated Expenses was $97,857 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Cue Biopharma 98.78 Mn 8.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 79,188.00
Dec 31, 2017 97,857.00
API Access

Cue Biopharma Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CUE&period=max&api_key=YOUR_API_KEY